Morgan Stanley Remains a Buy on BioNTech SE (BNTX)
Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
BioNTech SE ADR falls Monday, still outperforms market
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Starboard Value takes $1 billion stake in Pfizer: Reports
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
BioNTech (BNTX) Presents at Innovation Series: AI Day
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
Fintel on MSN12d
Morgan Stanley Upgrades BioNTech SE - Depositary Receipt () (BNTX)
Fintel reports that on September 24, 2024, Morgan Stanley upgraded their outlook for BioNTech SE - Depositary Receipt () ...
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated ...